Key result
Early implementation of extra-corporeal membrane oxygenation support and Oseltamivir led to complete recovery from cardiogenic shock in 2 weeks in an adult with H1N1-induced fulminant myocarditis.
Case Report (n=1)
Early implementation of ECMO and antiviral therapy can lead to complete recovery in adults with H1N1-induced fulminant myocarditis and cardiogenic shock.
May support early ECMO and antivirals in H1N1 myocarditis with shock; hypothesis-generating and requires validation in larger studies.
The worldwide outbreak of pandemic influenza A (H1N1 influenza) infection in 2009 caused numerous hospitalizations and deaths resulting from severe complications such as pneumonia, sepsis, and acute respiratory distress syndrome. Fulminant myocarditis caused by H1N1 infection has been reported in children but rarely in adults. We present an adult who contracted H1N1 infection followed by fulminant myocarditis. Early implementation of extra-corporeal membrane oxygenation support in conjunction with a specific anti-influenza viral medication (Oseltamivir) led to the patient's complete recovery from cardiogenic shock in 2 weeks.
No takes yet. Share an insight, caveat, or question.
Liao et al. (2011) conducted a case report in Fulminant myocarditis caused by H1N1 infection (n=1). Extra-corporeal membrane oxygenation (ECMO) and Oseltamivir was evaluated on Complete recovery from cardiogenic shock. Early implementation of extra-corporeal membrane oxygenation support and Oseltamivir led to complete recovery from cardiogenic shock in 2 weeks in an adult with H1N1-induced fulminant myocarditis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: